Press release
Oligonucleotide Therapeutics Market 2022 Global Projection By Key Players - PCI Biotech, SomaGenics, ContraVir, Alnylam, Regulus Therapeutics- Analysis and Forecast to 2024
Oligonucleotide Therapeutics Market 2022
Oligonucleotides are short chain RNA or DNA which are usually manufactured by utilizing automated synthesizers. Purification of the oligonucleotide is done by anion exchange chromatography which is followed by desalting and freezing technique. For the synthesis of siRNA duplex oligonucleotide, an annealing step is carried out where two purified oligonucleotide strands are brought together in an equimolar ratio.
Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/12787
Oligonucleotide therapeutics are different from conventional medicine as they can inhibit the expression of certain genes. This has given rise to innovative new oligonucleotides that can target specific genes and treat chronic diseases. The development of oligonucleotide therapeutics is done through chemically modified artificial nucleic acids. The artificial oligonucleotides are being developed which has improved in vivo stability and enhanced affinity to target mRNA.
The demand for oligonucleotides is expected to upsurge as there are very few approved molecules. This has offered oligonucleotide market players a wide scope to discover new molecular entities. Moreover, the technology upgrades of chemically synthesized oligonucleotides have led to the development of more stable and extended half-life molecules.
There are around 135 oligonucleotide therapeutics currently in different stages of drug development, which may further add to the limited three approved drugs currently available in the oligonucleotide therapeutics market.
Oligonucleotide Therapeutics Market: Segmentation
On the basis of application
Infectious diseases
Oncology
Neurodegenerative disorders
Cardiovascular diseases
Kidney diseases
Others
On the basis of type
Antisense
Ribozymes
Aptamers
miRNA
CpG/Immunostimulatory
RNAi
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/12787
The presence of the main market leaders, market consolidation and commercialization of new molecules are all contributing towards the dominating position of North America in the oligonucleotides therapeutic market. Miragen Therapeutics, Inc. agreed to merge with Signal Genetics, Inc for an initial investment of USD 40 million. Through this merger both the companies expect to develop micro RNA-targeted oligonucleotide clinical products.
New molecule application is also another strategy the market players are using to mark their presence in the oligonucleotide therapeutic market. Biogen recently received FDA approval for a new drug application for nusinersen. If approved, the antisense oligonucleotides molecule would be the first of its kind to be used for treating spinal muscular atrophy.
Asia-Pacific is the fastest growing region as several oligonucleotide therapeutics manufacturers are looking forward to establishing manufacturing facilities in this region. Moreover, research undertaking and funding in the synthesis of oligonucleotides are expected to add on to the increasing demand.
Recently, Daiichi Sankyo Co., Ltd. announced its intention to open up a new company named Orphan Disease Treatment Institute Co., Ltd. to treat Duchenne muscular dystrophy through its active ingredient ENA oligonucleotide. The company is a collaboration between Daiichi, Mitsubishi UFJ Capital Co., Ltd. and Innovation Network Corporation of Japan and looks forward to entering the oligonucleotide therapeutics market.
One of the major trends driving the oligonucleotides therapeutic market is the increasing licensing and collaboration activities. Moreover, the demand for advanced technologies in oligonucleotide therapeutics such as gene silencing through RNAi is gaining importance due to its high efficiency, thereby propelling the oligonucleotide therapeutics market.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/12787
Some of the key contributors to the oligonucleotide therapeutics market are PCI Biotech, SomaGenics, ContraVir, Alnylam, Regulus Therapeutics, Ionis Pharmaceuticals, Gilead, Santaris, InteRNA, miRage, Biogen, Merck and Pfizer, among others.
Key Questions Answered in the Oligonucleotide Therapeutics Market Report
How is the Oligonucleotide Therapeutics Market expected to grow over the projected period?
What direction is the Oligonucleotide Therapeutics Market expected to take in terms of volume and value during the forecast period?
What is the impact of macroeconomic factors on the Oligonucleotide Therapeutics Market in future?
What are the key market drivers in the Oligonucleotide Therapeutics Market?
What are significant opportunities and improvement areas for Oligonucleotide Therapeutics Market manufacturers?
What are the key developments and trends taking over the Oligonucleotide Therapeutics Market?
Which are the emerging countries that are expected to create significant growth opportunities in the Oligonucleotide Therapeutics Market?
Read Also-
MRI Systems Market - https://www.persistencemarketresearch.com/market-research/mri-systems-market.asp
Functional Brain Imaging Systems Market - https://www.persistencemarketresearch.com/market-research/functional-brain-imaging-systems-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against rep/uted organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oligonucleotide Therapeutics Market 2022 Global Projection By Key Players - PCI Biotech, SomaGenics, ContraVir, Alnylam, Regulus Therapeutics- Analysis and Forecast to 2024 here
News-ID: 2612203 • Views: …
More Releases from Persistence Market Research
IBC Rental Business Market Size Expected to Reach US$2.8 Billion by 2033 - Persi …
The IBC rental business market has emerged as a critical component of modern industrial logistics and packaging ecosystems, driven by the growing need for flexible cost efficient and sustainable bulk liquid and semi liquid handling solutions. Intermediate Bulk Containers are widely used for transporting and storing chemicals food ingredients pharmaceuticals and industrial liquids due to their standardized design durability and safety advantages. Renting IBCs rather than owning them has gained…
Rugged Cases Market Size to Reach US$1,371.1 Million by 2033 - Persistence Marke …
The rugged cases market has evolved into a critical segment within the broader protective packaging and equipment accessories industry, driven by the growing need to safeguard high value devices and sensitive equipment in harsh operating environments. Rugged cases are specifically engineered to provide superior protection against physical shocks vibration moisture dust and extreme temperatures. These cases are widely used across consumer electronics industrial equipment medical devices logistics military and government…
Magnetic Closure Boxes Market Forecast Shows Growth from US$1.1 Billion in 2026 …
The magnetic closure boxes market has emerged as a high value segment within the global rigid and premium packaging industry, driven by changing consumer expectations and brand strategies. Magnetic closure boxes are widely recognized for their premium aesthetics durability and reusability, making them a preferred packaging choice for luxury goods cosmetics electronics corporate gifting and high end retail products. These boxes combine rigid board construction with concealed magnetic mechanisms that…
Cold Chain Market to Reach US$ 919.9 Bn by 2032 as Key Players Lineage Logistics …
The cold chain market plays a critical role in maintaining the quality, safety, and efficacy of temperature-sensitive products across global supply chains. It encompasses a wide range of logistics solutions, including refrigerated storage, temperature-controlled transportation, monitoring systems, and handling infrastructure. Industries such as food and beverages, pharmaceuticals, biotechnology, and chemicals heavily rely on cold chain systems to prevent spoilage, contamination, and loss of product integrity. As global trade expands and…
More Releases for Oligonucleotide
Oligonucleotide Synthesis Market CAGR 9.9% by 2035, Due To The Growing Demand Fo …
According to our latest market report "Oligonucleotide Synthesis Market by Application Area, Type of Product Synthesized, Type of Oligonucleotide Synthesized, Scale of Operation, Therapeutic Area, End-users, Company Size and Key Geographical Regions: Industry Trends and Global Forecasts, Till 2035", the global oligonucleotide synthesis market size is projected to reach USD 13.5 billion by 2035 from USD 4.8 billion in 2024, growing at a CAGR of 9.9% in the forecast period…
Oligonucleotide Synthesis Market Outlook, 2030
The global oligonucleotide synthesis market is set to witness unprecedented growth in the coming decade, driven by advancements in biotechnology, increasing applications in genetic research, and rising demand for personalized medicine. According to market research, the global oligonucleotide synthesis market size was valued at USD 5.198 billion in 2020 and is projected to reach USD 26.09 billion by 2030, growing at a compound annual growth rate (CAGR) of 17.10% from…
Antisense Oligonucleotide Therapeutics Market
Antisense Oligonucleotide Therapeutics Market worth $ 64.64 Billion by 2030 - Exclusive Report by Insight Analytics
Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Antisense Oligonucleotide Therapeutics Market- by Therapy (Monotherapy and Combination), Molecule Target Indication (DNA Molecule and RNA Molecule), Target Indication (Duchenne Muscular Atrophy, Spinal Muscular Atrophy, Familial Chylomicronemia Syndrome, Amyotrophic Lateral Sclerosis, Familial Partial Lipodystrophy, Hereditary Transthyretin-Mediated (hatter) Amyloidosis, Huntington's Disease…
Oligonucleotide Therapy Market Transforming Healthcare: The Oligonucleotide Ther …
Oligonucleotide Therapy Market worth $19.92 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Oligonucleotide Therapy Market - (By Type (Antisense, Ribozymes, Aptamers, miRNA, CpG/Immunostimulatory, RNAi), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others), By End User
(Hospitals, Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According…
Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthes …
Researchmoz added latest report "Global Market Study on Oligonucleotide Synthesis: Custom Oligonucleotide Synthesis Service Type Segment to Hold 70% Market Share by 2025". The industry report lists the leading competitors and provides the insights strategic industry Analysis of the key factors influencing the market.
Our new research report on the global oligonucleotide synthesis market gives a brief overview of the global market. The report includes projections on the global oligonucleotide synthesis…
Oligonucleotide Synthesis Market 2017 Development Trends
This report studies the global Oligonucleotide Synthesis market, analyzes and researches the Oligonucleotide Synthesis development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Agilent Technologies
Biosearch Technologies
Eurofins Genomics
Eurogentec
Integrated DNA Technologies
Merck KGAA
Thermo Fisher Scientific
GeneDesign
Bio-Synthesis - CRO/CMO Life Sciences Company
Bioautomation
GE Healthcare
LGC Biosearch Technologies
NITTO Denko Avecia
For more information about this report at http://www.reportsweb.com/global-oligonucleotide-synthesis-market-size-status-and-forecast-2022
Market segment by Regions/Countries, this report…
